RE: Immunobody30 Jan 2022 18:05
RG never mentioned a specific price as I recall (you refer to the 'Frankfurt' video I presume) he said 'multiples of the current share price' I believe, which was the plan for selling the whole shooting match once SCIB1 was through clinical approval. And that was to sell SCIB1 plus everything that hangs off it, so the whole platform and all its potential. But I'm sure you remember that this was turned on its head with the advent of Moditope which was seen as a game changer - and all being well still is, possibly quite soon. I remember the visible disappointment on LD's face at the AGM when they announced a further delay to Moditope going into trial in 2016, but I'm sure you can see the underlying development of Moditope as well as Avidimab, Covidity and all the rest, and frustrating though this progress is, it is brewing positively imo, and I believe Vulpes and Redmile's involvement as things have (in a trader's eyes perhaps) slowed down, shows that as they say works of art take time, and the bigger the mass, the more it takes to make it move - but once it gets moving it can become unstoppable. That's why I'm still here anyway. Each to their own view anyway.